Leap Therapeutics Inc (LPTX) stock has risen 91.23% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives LPTX stock a score of 72 out of a possible 100.
That rank is chiefly influenced by a fundamental score of 94. In addition to the average rating from Wall Street analysts, LPTX stock has a mean target price of 5.1. This means analysts expect the stock to climb 133.94% over the next 12 months. LPTX's rank also includes a short-term technical score of 88. The long-term technical score for LPTX is 36.
What's Happening with LPTX Stock Today
Leap Therapeutics Inc (LPTX) stock is higher by 4.81% while the S&P 500 has risen 0.26% as of 10:45 AM on Thursday, Oct 22. LPTX has risen $0.10 from the previous closing price of $2.08 on volume of 476,635 shares. Over the past year the S&P 500 has gained 14.65% while LPTX has risen 91.23%. LPTX lost -$1.33 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Leap Therapeutics Inc (LPTX) Stock.
